Details of the Drug Reposition

General Information of This Drug (ID: DMJI3BA)

Drug Name
Peginterferon alfa-2a   DMJI3BA
Synonyms Pegasys; Peginterferon alfa-2a (genetical recombination); Peginterferon alfa-2a (USAN/INN); Peginterferon alfa-2a (genetical recombination) (JAN)
Therapeutic Class
Anticancer Agents

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Leukemia DISNAKFL N.A. Approved [1]
Chronic hepatitis B virus infection DISHL4NT N.A. Approved [2]
------------------------------------------------------------------------------------
2 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hepatitis C virus infection DISQ0M8R 1E51.1 Discontinued in Phase 2 [3]
Hairy cell leukaemia DISTD2E5 2A82.2 Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------

References

1 Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia. N Engl J Med. 2010 Dec 23;363(26):2511-21.
2 Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection. Hepatology. 2019 Jun;69(6):2338-2348.
3 Pregabalin for the Treatment of Vulvodynia
4 ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)